Emcure Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Emcure Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Emcure Pharmaceuticals Ltd.

16 Jul 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release titled - "Emcure Pharmaceuticals Ltd. and Sanofi India Limited Announce Exclusive Distribution Partnership to Broaden Reach of Sanofi''s Oral Anti-diabetic Drugs"

pdf

Emcure Pharmaceuticals Ltd.

14 Jul 2025, 01:12PM

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Appointment of Mr. R.S. Vasan as President - India Business and Senior Management Personnel of the Company w.e.f. July 14, 2025.

pdf

Emcure Pharmaceuticals Ltd.

10 Jul 2025

1353.40

0.33%

Emcure Pharma rises over 2% as USFDA issues Form 483 with Zero observations

Business Standard

Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) issued Form 483 with zero observations for its Sanand, Ahmedabad unit.

Emcure Pharmaceuticals Ltd. has gained 45.89% in the last 6 Months

Emcure Pharmaceuticals Ltd.

09 Jul 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection at our manufacturing facility (Oncology) located at Sanand, Ahmedabad, Gujarat, India

pdf

Emcure Pharmaceuticals Ltd.

09 Jul 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025

pdf

Emcure Pharmaceuticals Ltd.

04 Jul 2025

1353.40

0.33%

Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore

NDTV Profit

The public shareholder sold the 2.37% stake for Rs 1,250.44 apiece.

Emcure Pharmaceuticals Ltd. has gained 45.89% in the last 6 Months

Emcure Pharma shares dip after 2.4% stake change hands in block trades

Business Standard | 04 Jul 2025 1 more

Emcure Pharmaceuticals Ltd.

04 Jul 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with the name "Emcure Wellness Private Limited".

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1353.40

0.33%

SAST

Emcure Pharmaceuticals Ltd - 544210 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Submission of application for seeking re-classification from the " Promoter and Promoter Group'' category to ''Public'' category

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1353.40

0.33%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received from the Office of the Regional Director, Western Region, Ministry of Corporate Affairs, Mumbai, on June 24, 2025.

pdf